全文获取类型
收费全文 | 85913篇 |
免费 | 7941篇 |
国内免费 | 4044篇 |
专业分类
耳鼻咽喉 | 824篇 |
儿科学 | 1109篇 |
妇产科学 | 1472篇 |
基础医学 | 12259篇 |
口腔科学 | 2020篇 |
临床医学 | 8741篇 |
内科学 | 15275篇 |
皮肤病学 | 1289篇 |
神经病学 | 5287篇 |
特种医学 | 2813篇 |
外国民族医学 | 35篇 |
外科学 | 10974篇 |
综合类 | 9882篇 |
现状与发展 | 10篇 |
一般理论 | 8篇 |
预防医学 | 5314篇 |
眼科学 | 2286篇 |
药学 | 8361篇 |
32篇 | |
中国医学 | 2748篇 |
肿瘤学 | 7159篇 |
出版年
2024年 | 174篇 |
2023年 | 890篇 |
2022年 | 1971篇 |
2021年 | 2625篇 |
2020年 | 1791篇 |
2019年 | 1854篇 |
2018年 | 2330篇 |
2017年 | 1988篇 |
2016年 | 1894篇 |
2015年 | 2501篇 |
2014年 | 3196篇 |
2013年 | 3300篇 |
2012年 | 4605篇 |
2011年 | 4847篇 |
2010年 | 2954篇 |
2009年 | 2579篇 |
2008年 | 3533篇 |
2007年 | 3741篇 |
2006年 | 3479篇 |
2005年 | 3072篇 |
2004年 | 2490篇 |
2003年 | 2415篇 |
2002年 | 2209篇 |
2001年 | 5365篇 |
2000年 | 5258篇 |
1999年 | 4630篇 |
1998年 | 1796篇 |
1997年 | 1450篇 |
1996年 | 953篇 |
1995年 | 834篇 |
1994年 | 772篇 |
1993年 | 586篇 |
1992年 | 2136篇 |
1991年 | 1877篇 |
1990年 | 1752篇 |
1989年 | 1652篇 |
1988年 | 1435篇 |
1987年 | 1298篇 |
1986年 | 1171篇 |
1985年 | 984篇 |
1984年 | 649篇 |
1983年 | 501篇 |
1982年 | 272篇 |
1981年 | 201篇 |
1980年 | 151篇 |
1979年 | 299篇 |
1978年 | 87篇 |
1974年 | 94篇 |
1973年 | 108篇 |
1972年 | 84篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
23.
Parallel enzyme‐linked immunosorbent assay screening for human immunodeficiency virus among blood donors in five Chinese blood centres: a retrospective analysis 下载免费PDF全文
24.
Imre W.K. Kouw Bart B.L. Groen Joey S.J. Smeets Irene Fleur Kramer Janneau M.X. van Kranenburg Rachél Nilwik Jan A.P. Geurts René H.M. ten Broeke Martijn Poeze Luc J.C. van Loon Lex B. Verdijk 《Journal of the American Medical Directors Association》2019,20(1):35-42
Objectives
Short successive periods of skeletal muscle disuse have been suggested to substantially contribute to the observed loss of skeletal muscle mass over the life span. Hospitalization of older individuals due to acute illness, injury, or major surgery generally results in a mean hospital stay of 5 to 7 days, during which the level of physical activity is strongly reduced. We hypothesized that hospitalization following elective total hip arthroplasty is accompanied by substantial leg muscle atrophy in older men and women.Design and participants
Twenty-six older patients (75 ± 1 years) undergoing elective total hip arthroplasty participated in this observational study.Measurements
On hospital admission and on the day of discharge, computed tomographic (CT) scans were performed to assess muscle cross-sectional area (CSA) of both legs. During surgery and on the day of hospital discharge, a skeletal muscle biopsy was taken from the m. vastus lateralis of the operated leg to assess muscle fiber type–specific CSA.Results
An average of 5.6 ± 0.3 days of hospitalization resulted in a significant decline in quadriceps (?3.4% ± 1.0%) and thigh muscle CSA (?4.2% ± 1.1%) in the nonoperated leg (P < .05). Edema resulted in a 10.3% ± 1.7% increase in leg CSA in the operated leg (P < .05). At hospital admission, muscle fiber CSA was smaller in the type II vs type I fibers (3326 ± 253 μm2 vs 4075 ± 279 μm2, respectively; P < .05). During hospitalization, type I and II muscle fiber CSA tended to increase, likely due to edema in the operated leg (P = .10).Conclusions
Six days of hospitalization following elective total hip arthroplasty leads to substantial leg muscle atrophy in older patients. Effective intervention strategies are warranted to prevent the loss of muscle mass induced by short periods of muscle disuse during hospitalization. 相似文献25.
Xue Yao Yan Zhang Jian Hao Hui-Quan Duan Chen-Xi Zhao Chao Sun Bo Li Bao-You Fan Xu Wang Wen-Xiang Li Xuan-Hao Fu Yong Hu Chang Liu Xiao-Hong Kong Shi-Qing Feng 《中国神经再生研究》2019,(3)
Ferroptosis is an iron-dependent novel cell death pathway. Deferoxamine, a ferroptosis inhibitor, has been reported to promote spinal cord injury repair. It has yet to be clarified whether ferroptosis inhibition represents the mechanism of action of Deferoxamine on spinal cord injury recovery. A rat model of Deferoxamine at thoracic 10 segment was established using a modified Allen's method. Ninety 8-week-old female Wistar rats were used. Rats in the Deferoxamine group were intraperitoneally injected with 100 mg/kg Deferoxamine 30 minutes before injury. Simultaneously, the Sham and Deferoxamine groups served as controls. Drug administration was conducted for 7 consecutive days. The results were as follows:(1) Electron microscopy revealed shrunken mitochondria in the spinal cord injury group.(2) The Basso, Beattie and Bresnahan locomotor rating score showed that recovery of the hindlimb was remarkably better in the Deferoxamine group than in the spinal cord injury group.(3) The iron concentration was lower in the Deferoxamine group than in the spinal cord injury group after injury.(4) Western blot assay revealed that, compared with the spinal cord injury group, GPX4, xCT, and glutathione expression was markedly increased in the Deferoxamine group.(5) Real-time polymerase chain reaction revealed that, compared with the Deferoxamine group, mRNA levels of ferroptosis-related genes Acyl-CoA synthetase family member 2(ACSF2) and iron-responsive element-binding protein 2(IREB2) were up-regulated in the Deferoxamine group.(6) Deferoxamine increased survival of neurons and inhibited gliosis. These findings confirm that Deferoxamine can repair spinal cord injury by inhibiting ferroptosis. Targeting ferroptosis is therefore a promising therapeutic approach for spinal cord injury. 相似文献
26.
27.
28.
29.
Fuying Chen Linting Huang Changcan Li Jia Zhang Weiqin Yang Beibei Zhang Huaguo Li Dan Deng Jianying Liang Jinwen Shen Zhirong Yao Ming Li 《Clinical genetics》2020,98(2):179-184
Epidermolysis bullosa (EB) is a heritable blistering disorder. We performed a next-generation sequencing-based multigene panel test and successfully predicted 100% of the EB types, including, 36 EB simplex (EBS), 13 junctional EB (JEB), 86 dystrophic EB (DEB), and 3 Kindler EB. Chinese JEB and recessive DEB (RDEB) patients have relatively mild phenotypes; for severe type separately accounts for 45.5% and 23.8%, respectively. We identified 96 novel and 49 recurrent pathogenic variants in 11 genes, although we failed to detect the second mutation in one JEB and five RDEB patients. We identified one novel p.E475K mosaic mutation in the clinically normal mother of one out of 13 EBS patients with KRT5 mutations, one recurrent p.G2034R mosaic mutation, and one novel p.G2043R mosaic mutation in the clinically normal relatives of two out of 19 dominant DEB patients. This study shows that next-generation technology could be an effective tool in diagnosing EB. 相似文献
30.